THE FEASIBILITY OF USING RANDOMIZATION SCHEMES EARLY IN THE CLINICAL TRIALS OF NEW CHEMOTHERAPEUTIC AGENTS: HYDROXYUREA (NSC-32065).
D000970:Antineoplastic Agents; D035843:Biomedical Research; D004358:Drug Therapy; D006918:Hydroxyurea; D007970:Leukopenia; D011897:Random Allocation; D014116:Toxicology
D000970:Antineoplastic Agents; D006918:Hydroxyurea
ANTINEOPLASTIC AGENTS; CLINICAL RESEARCH; DRUG THERAPY; LEUKOPENIA; TOXICOLOGIC REPORT